ARL Bio Pharma
- Leann HewettChief Financial Officer · Web search
- Vince BobinChief Operations Officer · Web search
- Qiang LiuChief Scientific Officer · Web search
How we got $1.1M
Based on typical figures for its industry (2022 Economic Census), not its own records.
What we know
Employees over time
▲ 180% since 2023Show as table
| Year | Source | Employees | Est. revenue |
|---|---|---|---|
| 2023 | Form 5500 | 171 | $31.4M |
| 2024 | Form 5500 | 191 | $35.0M |
| 2025 | Form 5500 | 478 | $87.7M |
Participants are employees in the company's retirement plan at year end, from its Form 5500 filing with the Department of Labor. They usually run a little under total headcount (part-timers and new hires may not be eligible). Revenue and EBITDA apply this industry's revenue per employee and margin to each year's count.
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| ARL Bio Pharma this business | $1.7M | — |
| PROGENTEC DIAGNOSTICS, INC. Oklahoma City · 10 employees | $2.0M | 0.0 mi |
| Dr. James W. Smith, Md Oklahoma City | $1.7M | 0.3 mi |
| PET Imaging of Oklahoma City Oklahoma City | $1.7M | 0.4 mi |
| David P Ellis MD Oklahoma City | $1.7M | 0.4 mi |
| Besem Beteck Oklahoma City | $1.7M | 0.4 mi |
| Devon McFarland, MSRS, RRA ARRT Oklahoma City | $1.7M | 0.4 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $1.1M |
| Multiple for this size and industry | 3× |
| Value range | $299K – $2.0M |
This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Medical and Diagnostic Laboratories businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (22%). Treat these as a rough guide.
| Revenue range | $578K – $2.6M |
| EBITDA range | $124K – $565K |
| Industry (NAICS) | Medical and Diagnostic Laboratories (6215) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology
History & advisors
Advisors
- AccountingRose Rock CPASAudits its 401(k) plan (2025 filing)
From the company's own website and public filings (DOL Form 5500, IRS Form 990, SBA). Roles are as stated there and may be out of date.
Public records
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About ARL Bio Pharma
ARL Bio Pharma is a medical and diagnostic laboratories company in Oklahoma City, Oklahoma. Its estimated annual revenue is about $1.7M, with roughly $366K of EBITDA. It has about 478 employees. Its estimated business value is $1.1M (likely range $299K–$2.0M).
Common questions
- Who owns ARL Bio Pharma?
- The owner of ARL Bio Pharma isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does ARL Bio Pharma make?
- SeeBITDA estimates ARL Bio Pharma's annual revenue at about $1.7M (likely between $578K and $2.6M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is ARL Bio Pharma worth?
- About $1.1M, roughly 3× its estimated EBITDA of $366K, typical for a medical and diagnostic laboratories company its size. Likely range: $299K–$2.0M.
- How many employees does ARL Bio Pharma have?
- About 478, from its 2025 retirement-plan filing.